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Background
Hypoxic pulmonary vasoconstriction is a physiological
response enabling efficient oxygen delivery to tissues
during transient regional lung hypoxia. However, when
larger territories are involved, this adaptive mechanism
can be detrimental and chronically lead to maladapta-
tion. Such maladaptive events occur commonly due to
high altitude hypoxia or pathologies that cause wide-
spread, chronic pulmonary vasoconstriction resulting in
hypoxic pulmonary arterial hypertension (HPAH), mala-
daptive pulmonary vascular remodelling and right heart
failure. Previous work from our lab has shown protein
kinase G (PKG) 1a is susceptible to oxidation, forming
a disulfide dimer which directly activates the kinase
resulting in vasodilation and blood pressure lowering.
During hypoxia, pulmonary cells become pro-reducing.
In this study we tested the hypothesis that this may
alter the levels of oxidant-activated PKG1a and contri-
bute to HPAH pathogenesis.
Methods
A “redox-dead” Cys42Ser PKGIa knock-in (KI) mouse
which cannot be oxidant-activated was employed.
HPAH was induced by exposing mice to 10% O2 for
4 weeks. Cardiac function and pulmonary arterial stiff-
ness was assessed by echocardiography (VEVO 770,
Visual Sonics). Right ventricular pressure was measured
using a 1.2F pressure catheter (Scisence Inc). Vascular
reactivity was assessed using a tension myograph
(DMT). Tissues for molecular analysis were harvested
under hypoxic (10% O2) or normoxic conditions (room
air) respectively to reflect their treatment conditions.
Results
Acute in vitro hypoxia (60 min) resulted in a reduction
of PKG1a disulfide level in pulmonary artery (Fig. 1a).
A similar decrease in PKG1a disulfide levels was
observed in the lung tissue from mice exposed to acute
hypoxia (5-20min at 10% O2). In contrast, HPAH
induced by chronic in vivo hypoxia resulted in signifi-
cant increase of PKG1a disulfide in the lung tissue of
WT mice, while the level of PKG1a disulfide in the
right ventricle remained similar (Fig 1b-c). There was a
trend towards an increase in total PKG1a expression in
the lung and right ventricle. After exposure to chronic
hypoxia all mice developed HPAH, mild left ventricular
dysfunction and mild body weight loss. However, the KI
mice developed a more severe HPAH phenotype, i.e.
potentiated right ventricular hypertrophy, higher right
ventricular systolic pressure and pulmonary arterial stiff-
ness, compared to WT littermates (Fig. 1d-f). Despite
these differential changes, both genotypes had similar
compensatory increases in haematocrit and blood hae-
moglobin levels. Total lung weight was significantly
increased after chronic hypoxia; however there were no
differences between WT and KI mice. In addition, there
was no pronounced development of lung oedema in
either genotype. To provide insight into the potential
causative importance of PKG1a redox state in the con-
trol of pulmonary vasotone, we compared responses of
WT and KI isolated pulmonary arteries to H2O2. Under
normoxic conditions, KI pulmonary vessels had a small
but significant decrease in sensitivity to H2O2 (i.e. a
rightward shifted dose-response) compared to WT; this
was despite equal constriction to the pressor agonist
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U-46619 in each genotype. Experiments comparing vas-
cular reactivity in WT and KI mice after HPAH employ-
ing both tension myograph and mouse isolated lung
approaches are in progress.
Conclusion
We conclude that PKG1a plays a role in both acute
hypoxic vasoconstriction as well as changes during
chronic HPAH. We speculate that disulfide PKG1a
levels are lowered, by chemical reduction, during acute
hypoxia – potentially contributing to acute hypoxic pul-
monary vasoconstriction. In contrast, during chronic
hypoxia there is exacerbated PKG1a oxidation which
may be protective by keeping the pulmonary arterial
pressure low, and thereby reducing the afterload on the
right ventricle in the setting of HPAH. Redox dead
PKG1a KI mice lack this protective mechanism and
therefore have exacerbated hypoxia-induced pulmonary
hypertension phenotype. Interventions targeting PKG1a
oxidation in the pulmonary vasculature will help to test
if this mechanism truly serves to attenuate HPAH pro-
gression and consequent right heart failure.
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Figure 1. Differential responses of WT or Cys42Ser PKGIa KI tissues to acute or chronic hypoxia (a) Decrease in PKG1a disulfide levels in
mouse pulmonary artery under acute hypoxia. (b) PKG1a disulfide formation in mouse lung and (c) right ventricle after chronic hypoxia. (d)
Fulton index, (e) Right ventricle systolic pressure and (f) pulmonary flow velocity in KI mice compared with WT mice after HPAH. *p≤0.05,
**p≤0.01, ***p≤0.001, by t-test. n=8-10/group.
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